These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 12851051)

  • 61. Preliminary investigation on the design of biodegradable microparticles for ivermectin delivery: set up of formulation parameters.
    Dorati R; Genta I; Colzani B; Tripodo G; Conti B
    Drug Dev Ind Pharm; 2015; 41(7):1182-92. PubMed ID: 24994001
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Preparation and characterization of propranolol hydrochloride nanoparticles: a comparative study.
    Ubrich N; Bouillot P; Pellerin C; Hoffman M; Maincent P
    J Control Release; 2004 Jun; 97(2):291-300. PubMed ID: 15196756
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Full factorial design optimization of anti-inflammatory drug release by PCL-PEG-PCL microspheres.
    Azouz L; Dahmoune F; Rezgui F; G'Sell C
    Mater Sci Eng C Mater Biol Appl; 2016 Jan; 58():412-9. PubMed ID: 26478328
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Microencapsulation of cytarabine using poly(ethylene glycol)-poly(epsilon-caprolactone) diblock copolymers as surfactant agents.
    Diab R; Hamoudeh M; Boyron O; Elaissari A; Fessi H
    Drug Dev Ind Pharm; 2010 Apr; 36(4):456-69. PubMed ID: 19877831
    [TBL] [Abstract][Full Text] [Related]  

  • 65. In vitro evaluation of gentamicin released from microparticles.
    Blanco-Príeto MJ; Lecaroz C; Renedo MJ; Kunkova J; Gamazo C
    Int J Pharm; 2002 Aug; 242(1-2):203-6. PubMed ID: 12176247
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Microencapsulation of antimicrobial ceftiofur drugs.
    Bodmeier R; Chen H; Davidson RG; Hardee GE
    Pharm Dev Technol; 1997 Nov; 2(4):323-34. PubMed ID: 9552461
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The preparation and evaluation of poly(epsilon-caprolactone) microparticles containing both a lipophilic and a hydrophilic drug.
    Hombreiro Pérez M; Zinutti C; Lamprecht A; Ubrich N; Astier A; Hoffman M; Bodmeier R; Maincent P
    J Control Release; 2000 Apr; 65(3):429-38. PubMed ID: 10699300
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Long-term release of clodronate from biodegradable microspheres.
    Perugini P; Genta I; Conti B; Modena T; Pavanetto F
    AAPS PharmSciTech; 2001 Jul; 2(3):E10. PubMed ID: 14727869
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A poly(D,L-lactide-co-glycolide) microsphere depot system for delivery of haloperidol.
    Cheng YH; Illum L; Davis SS
    J Control Release; 1998 Nov; 55(2-3):203-12. PubMed ID: 9795060
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Microencapsulation of protein drugs for drug delivery: strategy, preparation, and applications.
    Ma G
    J Control Release; 2014 Nov; 193():324-40. PubMed ID: 25218676
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Preparation of biodegradable microspheres and matrix devices containing naltrexone.
    Dinarvand R; Moghadam SH; Mohammadyari-Fard L; Atyabi F
    AAPS PharmSciTech; 2003; 4(3):E34. PubMed ID: 14621966
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Polyethylenglycol-co-poly-D,L-lactide copolymer based microspheres: preparation, characterization and delivery of a model protein.
    Dorati R; Genta I; Tomasi C; Modena T; Colonna C; Pavanetto F; Perugini P; Conti B
    J Microencapsul; 2008 Aug; 25(5):330-8. PubMed ID: 18465305
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effect of preparation temperature on the characteristics and release profiles of PLGA microspheres containing protein fabricated by double-emulsion solvent extraction/evaporation method.
    Yang YY; Chia HH; Chung TS
    J Control Release; 2000 Oct; 69(1):81-96. PubMed ID: 11018548
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Ammonolysis-based microencapsulation technique using isopropyl formate as dispersed solvent.
    Im HY; Sah H
    Int J Pharm; 2009 Dec; 382(1-2):130-8. PubMed ID: 19715744
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Preparation and characterization of biodegradable polyhydroxybutyrate-co-hydroxyvalerate/polyethylene glycol-based microspheres.
    Monnier A; Rombouts C; Kouider D; About I; Fessi H; Sheibat-Othman N
    Int J Pharm; 2016 Nov; 513(1-2):49-61. PubMed ID: 27593898
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Solvent influence on spray-dried biodegradable microspheres.
    Bain DF; Munday DL; Smith A
    J Microencapsul; 1999; 16(4):453-74. PubMed ID: 10420331
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Japanese encephalitis virus vaccine formulations using PLA lamellar and PLG microparticles.
    Yeh MK; Coombes AG; Chen JL; Chiang CH
    J Microencapsul; 2002; 19(5):671-82. PubMed ID: 12433308
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Preparation of microcapsules and control of their morphology.
    Kiyoyama S; Shiomori K; Kawano Y; Hatate Y
    J Microencapsul; 2003; 20(4):497-508. PubMed ID: 12851050
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effect of WOW process parameters on morphology and burst release of FITC-dextran loaded PLGA microspheres.
    Mao S; Xu J; Cai C; Germershaus O; Schaper A; Kissel T
    Int J Pharm; 2007 Apr; 334(1-2):137-48. PubMed ID: 17196348
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Monitoring microviscosity and microacidity of the albumin microenvironment inside degrading microparticles from poly(lactide-co-glycolide) (PLG) or ABA-triblock polymers containing hydrophobic poly(lactide-co-glycolide) A blocks and hydrophilic poly(ethyleneoxide) B blocks.
    Mäder K; Bittner B; Li Y; Wohlauf W; Kissel T
    Pharm Res; 1998 May; 15(5):787-93. PubMed ID: 9619791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.